Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

Abstract Background Alzheimer’s Disease (AD) and Fronto temporal lobar dementia (FTLD) are common causes of dementia in the aging population for which limited therapeutical options are available. These disorders are associated with Tau accumulation. We have previously shown that CerebrolysinTM (CBL)...

Full description

Bibliographic Details
Main Authors: Edward Rockenstein, Kiren Ubhi, Margarita Trejo, Michael Mante, Christina Patrick, Anthony Adame, Philipp Novak, Marion Jech, Edith Doppler, Herbert Moessler, Eliezer Masliah
Format: Article
Language:English
Published: BMC 2014-07-01
Series:BMC Neuroscience
Subjects:
Tau
GSK3β
Drp-1
Neuroprotection
Alzheimer’s disease
Tauopathies
Online Access:https://doi.org/10.1186/1471-2202-15-90

Internet

https://doi.org/10.1186/1471-2202-15-90

Similar Items